Holdings of Resmed Inc. (RMD) are aligned with the stars

With 0.64 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.11 million shares. During the session, the Medical Instruments & Supplies company that operates in wider Healthcare sector, reached to the highest price of $221.795 whereas the lowest price it dropped to was $217.67. The 52-week range on RMD shows that it touched its highest point at $232.99 and its lowest point at $132.24 during that stretch. It currently has a 1-year price target of $219.88. With its current market cap of 32.41 billion, RMD has annualized dividend of $1.92 while the current yield stands at 0.87%. RMD paid its most recent dividend on 1715126400, while the ex-dividend date for that was 1715126400. Beta for the stock currently stands at 0.70.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of RMD was up-trending over the past week, with a rise of 3.64%, but this was up by 19.35% over a month. Three-month performance surged to 22.20% while six-month performance rose 54.37%. The stock lost -5.10% in the past year, while it has gained 28.26% so far this year. A look at the trailing 12-month EPS for RMD yields 6.50 with Next year EPS estimates of 8.76. For the next quarter, that number is 2.08. This implies an EPS growth rate of 19.97% for this year and 13.37% for next year. EPS is expected to grow by 13.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 22.66%.

Float and Shares Shorts:

At present, 147.06 million RMD shares are outstanding with a float of 145.73 million shares on hand for trading. On 2024-04-30, short shares totaled 9.85 million, which was 670.0 higher than short shares on 1711584000. In addition to Mr. Michael J. Farrell BE, MBA, SM as the firm’s CEO & Chairman, Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScD serves as its Founder, Chair Emeritus & Director.

Institutional Ownership:

Through their ownership of 0.58771 of RMD’s outstanding shares, institutional investors have minority control over the company.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-03-31, RMD reported revenue of $1196980000.0 and operating income of $374584000.0. The EBITDA in the recently reported quarter was $429226000.0 and diluted EPS was $2.04.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for RMD since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.